BIB: ProShares Ultra Nasdaq Biotechnology - 48.95, $0.00M, 1.27 (2.66%)
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Past BIB reports
|Earning Date||Time||Title||EPS-e||EPS-a||Close||Prev Close||Open||Day Low||Day High||Gap %||CFO %||Change %||Volume|
Redbook 8:55 AM ET FHFA House Price Index 9:00 AM ET S&P Corelogic Case-Shiller HPI 9:00 AM ET New Home Sales 10:00 AM ET Consumer Confidence 10:00 AM ET Richmond Fed Manufacturing Index 10:00 AM ET State Street Investor Confidence Index 10:00 AM ET 4-Week Bill Auction 11:30 AM ET 52-Week Bill Auction 11:30 AM ET 2-Yr Note Auction 1:00 PM ET
AAII Sentiment SurveyBULL^ neut ^ BEAR